Skip to main content
Current Alzheimer Research publishes peer-reviewed frontier review and research articles on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Publisher: Bentham Science Publishers

More about this publication?
Volume 14, Number 4, 2017

Articles

Free Content Editorial: Current and Emerging Therapeutics in AD
pp. 354-355(2)
Authors: Sabbagh, Marwan; Decourt, Boris

Favourites:
ADD

Deep Brain Stimulation for Alzheimer’s Disease
pp. 356-361(6)
Authors: S. Xu, David; A. Ponce, Francisco

Favourites:
ADD

Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer’s Disease
pp. 377-392(16)
Authors: R. Kamkwalala, Asante; A. Newhouse, Paul

Favourites:
ADD

Conformation as the Therapeutic Target for Neurodegenerative Diseases
pp. 393-402(10)
Authors: Krishnan, Rajaraman; Hefti, Franz; Tsubery, Haim; Lulu, Michal; Proschitsky, Ming; Fisher, Richard

Favourites:
ADD

Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer’s Disease: Results from a Double-Blind, Placebo-Controlled Trial
pp. 403-411(9)
Authors: Decourt, Boris; Drumm-Gurnee, Denise; Wilson, Jeffrey; Jacobson, Sandra; Belden, Christine; Sirrel, Sherye; Ahmadi, Michael; Shill, Holly; Powell, Jessica; Walker, Aaron; Gonzales, Amanda; Macias, Mimi; N. Sabbagh, Marwan

Favourites:
ADD

Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
pp. 412-425(14)
Authors: Decourt, Boris; K. Lahiri, Debomoy; N. Sabbagh, Marwan

Favourites:
ADD

Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
pp. 412-425(14)
Authors: Decourt, Boris; K. Lahiri, Debomoy; N. Sabbagh, Marwan

Favourites:
ADD
Favourites:
ADD

Integrated Biomarkers for Depression in Alzheimer’s Disease: A Critical Review
pp. 441-452(12)
Authors: Wenzler, Sofia; Knochel, Christian; Balaban, Ceylan; Kraft, Dominik; Kopf, Juliane; S. Alves, Gilberto; Prvulovic, David; F. Carvalho, Andre; Oertel-Knochel, Viola

Favourites:
ADD

Serum Starvation Induces BACE1 Processing and Secretion
pp. 453-459(7)
Authors: V. Stavropoulou, A.; Mavrofrydi, O.; Saftig, P.; Efthimiopoulos, S.

Favourites:
ADD

Prevalence, Incidence, Risk and Protective Factors of Amnestic Mild Cognitive Impairment in the Elderly in Shanghai
pp. 460-466(7)
Authors: Wang, Tao; Xiao, Shifu; Chen, Kewei; Yang, Cece; Dong, Shuhui; Cheng, Yan; Li, Xia; Wang, Jinghua; Zhu, Minjie; Yang, Fuzhong; Li, Guanjun; Su, Ning; Liu, Yuanyuan; Dai, Jing; Zhang, Mingyuan

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content